认知和神经精神病学概况区分非典型的帕金森综合征
Michele T Hu1,2, Agustin Querejeta Coma2, James B Rowe3,4
1Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford and Oxford University Hospitals NHS Trust, Oxford, OX3 9DU, UK.
Brain : a journal of neurology
|April 16, 2025
概括
与帕金森病 (PD) 相比,非典型的帕金森综合征 (PSP,CBS,MSA) 显示出不同的认知和精神病特征. 神经精神学特征更好地区分这些综合征,有助于早期诊断和管理.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 认知科学 认知科学
背景情况:
- 非典型帕金森综合征 (APS) 存在诊断挑战,原因是与帕金森病 (PD) 和前性痴呆症的症状重叠.
- 晚期诊断APS影响患者的管理和预后,突出需要改进的诊断工具.
- 认知和精神病学特征可能为区分APS和PD提供有价值的见解.
研究的目的:
- 为了比较渐进性超核性 (PSP),皮质核综合征 (CBS),多系统缩 (MSA) 和异常性帕金森病 (PD) 的认知和精神病学概况.
- 确定可以提高APS in vivo诊断准确性的特征.
- 在这些条件下探索认知功能,运动严重程度和疾病持续时间之间的关系.
主要方法:
- 整合了来自PROSPECT和牛津发现队伍的横截面,多中心基线数据 (n=1138).
- 使用多重线性回归的数据的协调和比较.
- 使用床边查工具评估认知和精神特征,并分析血神经丝光链 (NFL) 水平.
主要成果:
- 观察到不同的认知特征:前额执行功能障碍在PSP中,视觉空间缺陷在CBS中,与PD相比,MSA中较轻微的缺陷.
- 神经精神特征,特别是冷漠和抑郁/焦虑,在区分APS时比认知领域更有效.
- 认知缺陷导致日常生活受损,并开发了一个分类器来改善APS的体内诊断.
结论:
- 认知和神经精神病学评估可以显著帮助区分APS和PD.
- 这项研究为开发分类器提供了基础,以提高APS的早期和准确诊断.
- 具有神经病理验证的纵向研究对于完善PSP,CBS,MSA和其他APS的诊断工具至关重要.
相关概念视频
Parkinson's Disease: Overview
323
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
323
Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
277
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
277
Personality Disorders: Paranoid and Schizoid
11
Personality disorders represent enduring cognition, affect, and behavior patterns that significantly deviate from societal norms. These maladaptive traits often lead to difficulties in various domains, including interpersonal relationships, occupational settings, and overall psychological well-being. Paranoid personality disorder and schizoid personality disorder are two distinct conditions marked by odd or eccentric behavior.
Paranoid Personality Disorder
Paranoid personality disorder is...
Paranoid Personality Disorder
Paranoid personality disorder is...
11
Alzheimer's Disease: Overview
328
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
328


